SEC Filing Summary: Local Bounti Corporation (8-K)
Business Context and Reporting Period
Company: Local Bounti Corporation (LOCL)
Filing Date: February 5, 2026 (Event Date)
Reporting Period: Current Report on Form 8-K
Context: The Company, incorporated in Delaware and listed on the New York Stock Exchange (NYSE), reported receiving a formal notice regarding non-compliance with continued listing standards.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin data. However, it discloses the following financial thresholds triggering the listing notice:
- Market Capitalization: Average global market capitalization over a consecutive 30 trading-day period was less than $50 million.
- Stockholders' Equity: Last reported stockholders' equity was less than $50 million.
- Debt and Liquidity: The filing text does not provide a clear value for debt levels or liquidity positions.
Material Changes and Listing Status
On February 5, 2026, the NYSE issued a notice stating the Company failed to satisfy Rule 802.01B (Minimum Market Capitalization Standard). This deficiency is based on the simultaneous failure to meet the $50 million market capitalization and $50 million stockholders' equity requirements. The stock continues to trade on the NYSE during the cure period, but delisting proceedings may be initiated if compliance is not restored.
Guidance, Outlook, and Risks
Management Plan: The Company intends to submit a plan to the NYSE within 45 days of receipt of the notice. This plan must demonstrate definitive actions to restore compliance within nine months (the "Market Capitalization Cure Period").
Outlook: Management is considering all available options to regain compliance but provided no assurances that the listing will be maintained.
Risks:
- Failure to submit a timely plan or have it accepted by the NYSE.
- Insufficient progress during the nine-month cure period.
- Potential suspension and delisting of common stock prior to the end of the cure period.
Investor Verification Checklist
- Verify the specific date the 45-day deadline for submitting the compliance plan expires.
- Monitor the Company's upcoming filings for the detailed "Market Capitalization Cure Plan."
- Review the most recent Form 10-K (filed March 31, 2025) for detailed financial statements regarding stockholders' equity and debt.
- Track the Company's stock price and trading volume to assess progress toward the $50 million market capitalization threshold.
- Confirm whether the Company has elected to use the extended transition period as an emerging growth company.